Buprenorphine And Naloxone Film
Product Images NDC 3215-6521

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 3215-6521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aveva Drug Delivery Systems Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure3.jpg (Figue3)

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Figure2.jpg (Figure2)

FDA Label Image

Figure4.jpg (Figure4)

FDA Label Image

Ctn2mg (Image01)

This text contains information about Buprenorphine and Naloxone Sublingual Film, warning about accidental ingestion by children and emphasizing the importance of keeping it out of their reach. It also instructs not to cut, chew, or swallow the film. The product is meant to be dispensed with an enclosed Medication Guide to each patient and should be stored at specific temperatures. It provides details about the composition and dosage of the film and highlights the need for emergency medical care in case of ingestion by children.*

FDA Label Image

Ctn4mg (Image02)

This text appears to be a description of a medication labeled as "Buprenorphine and Naloxone Sublingual Film" with a strength of 4 mg/1 mg. It mentions the potential danger for children accidentally ingesting the film and the need for emergency medical care in such cases. The instructions indicate that the sublingual film should be kept out of reach of children, not cut, chewed, or swallowed. It also provides guidance for pharmacists on how to dispense the medication and mentions a medication guide enclosed for each patient. The text includes details about the content of the pouches containing the sublingual film.*

FDA Label Image

Ctn8mg.jpg (Image03)

FDA Label Image

Ctn12mg.jpg (Image04)

This text appears to provide important instructions and information related to a medication called Buprenorphine and Naloxone Sublingual Film, with a dosage of 12 mg/3 mg. It includes details such as keeping the film out of reach of children, the proper administration method by placing it under the tongue, and guidance for pharmacists. Additionally, it mentions specific directions for dispensing the enclosed Medication Guide to each patient. The text also indicates that each box contains 30 pouches, and it lists the National Drug Code (NDC) for identification. Overall, this is essential information for healthcare professionals and patients using this medication.*

FDA Label Image

Structurebuprenorpine.jpg (Structurebuprenorpine)

FDA Label Image

Structurenaloxone.jpg (Structurenaloxone)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.